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LACK OF SCLEROSTIN PROMOTES OSTEOARTHRITIS BY ACTIVATING
CANONICAL AND NON-CANONICAL WNT PATHWAYS
W. Bouaziz, T. Funck-Brentano, H. Lin, C. Marty, E. Hay, M. Cohen-Solal.
Inserm U1132, Paris, France
Purpose: Sclerostin is a Wnt inhibitor produced by mineralizing cells
such as osteocytes. Sclerostin is also expressed in OA chondrocytes and
therefore might regulate the cartilage homeostasis in osteoarthritis
through the inhibition of Wnt pathways. We aimed here to assess the
role of sclerostin in the chondrocyte metabolism and the development
of osteoarthritis in SOST-deﬁcient mice.
Methods: Joint instability was induced by partial transsection of the
meniscus (MNX) in 10 week-old SOST-KO and wild type (WT) mice.
Mice were sacriﬁced at 4, 6 or 9 weeks after MNX.We analyzed: 1) bone
parameters such as bone volume/tissue volume (BV/TV) at the medial
femoral condyle, 2) the osteophyte volume by microCT, 3) the cartilage
damage using OA score and 4) the expression of matrix proteins. The
role of sclerostin in chondrocyte metabolism was investigated in pri-
mary murine chondrocytes culturedwithWnt3a and sclerostin (RT-PCR
and WB). Functional effect was assessed by the release of proteoglycan
content in the culture supernatant and the accumulation of GAGs by
Alcian blue staining. We next investigated the role of b-catenin / JNK
pathway using SP600125 inhibitor.
Results: Sclerostin expression was restricted to the calciﬁed cartilage
and osteocytes in WT mice and was enhanced with the development of
OA. In sham-knees, cartilage structure was preserved in SOST-KO mice
at any time despite a marked high BV/TV. MNX resulted in a higher OA
score in SOST-KOmice than inWTatWeek 4 (6.66 0.57 vs 3.25 0.95,
p<0.05) and Week 6 (11  1 vs 7  0.81, p<0.05), along with an
increased expression in type X collagen and Adamts-4 that suggested an
enhanced catabolism of chondrocytes. However, the osteophyte volume
was not affected by the lack of sclerostin at Week 4 (0.033  0.019 vs
0.024  0.01, p: NS) and at Week 6 (0.023  0.01 vs 0.02  0.01, p: NS).
In primary murine chondrocytes, Wnt3a reduced the proteoglycan
release which was rescued by sclerostin. Wnt3a increased the expres-
sion of Adamts-4 & -5, MMP-3 & -13 and type X collagen, while this
effect was totally abolished by sclerostin through an inhibition of the
Wnt canonical pathway. Moreover, Wnt3a promoted the phosphor-
ylation of JNK which was inhibited by sclerostin. We further inves-
tigated whether sclerostin-induced inhibition of JNK affects
chondrocyte anabolism. In Wnt-induced chondrocytes, sclerostin res-
cued the accumulation of GAGs and the expression of the anabolic
genes when JNK pathway was inhibited. In contrast, sclerostin did not
affect the CamK pathway.
Conclusions: Lack of sclerostin results in cartilage damage and disrupts
the balance of anabolism/catabolism in OA induced by joint instability.
Sclerostin inhibits both Wnt canonical pathway and the non canonical
JNK pathway, thereby preserving the chondrocyte metabolism. These
data suggest an important role of sclerostin in cartilage integrity in OA.
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MICE LACKING ONCOSTATIN M RECEPTOR EXPRESSION SHOW
REDUCED SYNOVIAL INFLAMMATION AND CARTILAGE DAMAGE,
BUT INCREASED BONE LOSS IN RESPONSE TO JOINT INJURY
B.A. Tonkin y, N. Jansz y, J. Johnson y, E. Romas z, N.A. Sims y,x,
N.C. Walsh y,x. y St Vincent’s Inst. of Med. Res., Melbourne, Australia;
zDept. Rheumatology, St Vincent’s Hosp., Melbourne, Australia; xDept
Med., St Vincent’s Hosp., Univ. of Melbourne, Melbourne, Australia
Purpose: Regardless of the inciting event, mild inﬂammation within the
synovium, progressive loss of articular cartilage, osteophyte formation
and accrual of subchondral bone are characteristic features of osteo-
arthritis (OA). The cytokine oncostatinM (OSM) is found at elevated levels
in human OA synovial ﬂuid and is a candidate for contributing to OA
pathogenesis. In synovialﬁbroblasts and osteoblastsOSM, signaling via its
ligand-speciﬁc receptor, OSMR, induces expression of pro-inﬂammatory
cytokines such as IL-6, cartilage degrading enzymes and the pro-osteo-
clastic factor, RANKL. We have also shown that OSM can augment IL-1
actions in synovial ﬁbroblasts by increasing expression of IL-1R1.We
hypothesized that,mice lackingexpression of OSMR (OSMRKOmice)may
be protected from injury-induced osteoarthritic-joint damage.
Methods: 12-week old male OSMR KO mice and their wildtype litter-
mates (OSMR WT) underwent surgical transection of the medial
meniscotibial ligament (DMM) or sham surgery on the right knee. Hindlimbs were collected and analysed at 8 weeks post-surgery. Bone
structure was analysed by ex-vivo micro-CT (Skyscan). Aggrecan loss
and cartilage damage were assessed according to the OARSI histologic
scoring scheme. Synovial inﬂammation was assessed using a modiﬁed
scoring scheme typically used for inﬂammatory arthritis. Statistics: 2-
way ANOVA, Sidak multiple comparisons post-hoc tests.
Results: At 8 weeks post-surgery in OSMR WT mice, increased loading
within the medial compartment of the tibia resulted in a focal increase
in medial subchondral bone (bone volume/tissue volume, BV/TV) in
DMM tibiae compared to sham tibiae. In contrast, OSMR KO mice
showed reduced BV/TV at this site in DMM tibiae compared to sham
tibiae (p<0.01). Furthermore, tibial metaphyseal trabecular BV/TV was
also reduced in OSMR KO DMM tibiae compared to sham tibiae
(p<0.01); this was not observed in OSMRWT mice. Although OSMR KO
mice showed similar levels of DMM-induced aggrecan loss compared to
OSMR WT mice, structural cartilage damage was reduced (p<0.05) in
the OSMR KO mice. Furthermore OSMR KO mice also showed reduced
synovial inﬂammation (p<0.05) compared to OSMR WT mice.
Conclusions: Together our data indicate that OSM signalling via OSMR
contributes to synovial inﬂammation and cartilage destruction in
response to joint injury. Surprisingly, OSMR KO mice showed a reduc-
tion in subchondral bone and metaphyseal trabecular bone in DMM-
tibiae compared to sham tibiae suggesting that OSMR-mediated sig-
nalling is also critical in limiting bone loss in these conditions.
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CARTILAGE-SPECIFIC DELETION OF MTOR UPREGULATES
AUTOPHAGY AND PROTECTS MICE FROM OSTEOARTHRITIS.
Y. Zhang, F. Vasheghani, Y. Li, M. Blati, S. Kayla, H. Fahmi, B. Lussier,
J-P. Pelletier, J. Martel-Pelletier, M. Kapoor. Univ. of Montreal, Montreal,
QC, Canada
Purpose: Recent studies suggest that the process of autophagy, a form
of programmed cell survival, is impaired during osteoarthritis (OA) and
may contribute towards decreased chondroprotection in the articular
cartilage associated with OA pathophysiology. mTOR (a serine/threo-
nine protein kinase) is a major repressor of autophagy. The exact role of
mTOR in OA pathophysiology is largely unknown. We determined the
expression of mTOR and known autophagy genes in human OA cartilage
as well as mouse and dog models of experimental OA. We also created
cartilage-speciﬁc mTOR knockout (KO) mice to determine the speciﬁc
role of mTOR in OA pathophysiology and autophagy signalling in vivo.
Methods: Human normal and OA cartilage was subjected to human
autophagy PCR array, western blotting, qPCR and immunohistochem-
istry. Inducible cartilage-speciﬁc mTOR KO mice were generated and
subjected to mouse model of OA. Human OA chondrocytes were treated
with rapamycin and ULK1 (most upstream autophagy inducer) SiRNA to
determine mTOR signalling pathway.
Results: mTOR is overexpressed in human OA patient cartilage as well
as mouse and dog experimental OA. Upregulation of mTOR expression
co-relates with increased chondrocyte apoptosis and reduced expres-
sion of key autophagy genes during OA. Subsequently, we show for the
ﬁrst time that cartilage-speciﬁc ablation of mTOR results in increased
autophagy signalling and a signiﬁcant protection from DMM-induced
OA associated with a signiﬁcant reduction in the articular cartilage
degradation, cell death and synovial ﬁbrosis. Furthermore, we show
that mTOR is responsible for shutting down ULK1/autophagy signalling
pathway resulting in the imbalance in the expression of catabolic and
anabolic factors in human OA chondrocytes.
Conclusions: This study for the ﬁrst time provides a direct evidence of
the role of mTOR and its downstream modulation of autophagy in
articular cartilage homeostasis. Thus targeting cellular homeostasis
mediators, such as mTOR and its downstream signaling by ULK1/
autophagy pathwaymay be a promising therapeutic strategy to achieve
chondroprotection and correct the imbalance between catabolic and
anabolic processes during OA and related disorders.
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MITOPHAGY DYSFUNCTION LOCALISES TO REGIONS OF NATURAL
OSTEOARTHRITIS IN STR/ORT MICE
K.A. Staines y, L. Wood y, M. Mainenti y, M. Hopkinson y, S. Mirczuk y,
R.C. Fowkes y, M. Campanella y,z, A.A. Pitsillides y. y The Royal Vet. Coll.,
London, United Kingdom; zUCL Consortium for Mitochondrial Res.,
London, United Kingdom
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S341Purpose:Mitophagy, the process of mitochondrial autophagy involving
selective sequestration and subsequent degradation of dysfunctional
mitochondria, is implicated in numerous aging-related diseases.
Molecularly controlled by the PINK-1/Parkin pathway, the efﬁcient
Parkin/PARK2 mediated ubiquitination of mitochondrial proteins is the
acknowledged keymechanism. Changes inmitochondrial function have
been implicated as an underpinning molecular event that leads to
articular cartilage (AC) degeneration and are likely to contribute to
osteoarthritis development. We have explored the hypothesis that
articular chondrocyte mitophagy is an early event taking place in car-
tilage that predisposes to OA onset, and have therefore explored
whether mitophagic markers are modiﬁed at various disease stages in
the natural STR/Ort mouse model of osteoarthritis in which AC degra-
dation is initially observed in the medial tibia plateau.
Methods: STR/Ortmouse knee joints from stages before, at onset, and at
advancing osteoarthritis stages and age-matched CBA (control) joints
were examined by immunohistochemical labelling of autophagy
markers (LC3), a protein core to mitochondrial function (VDAC) and one
recently described as an inhibitor of the Parkin/PARK2-mediated
ubiquitination of proteins (TSPO), both localised on the outer mem-
brane of mitochondria. Hip cartilage explants from 3-4 week-old STR/
Ort and CBA mice were also cultured for 24hrs, in absence or presence
of 100nM rapamycin, an inducer of macro-autophagy that is likely to
also impact the targeted type of autophagy, and mRNA transcripts for a
variety cartilage markers assessed by both standard and multiplex PCR
analysis. Proteoglycan release from hip cap explants was assessed by a
colorimetric assay for aggrecan quantiﬁcation.
Results: Immunolabelling for TSPO in non-OA prone CBA control mice
revealed positive chondrocyte expression in all AC compartments that
remained consistent in mice at all ages studied. In contrast, labelling
revealed an advancing age-related decline in AC chondrocyte expres-
sion of TSPO in chondrocytes of the lateral (unaffected) tibial plateau in
STR/Ort mouse joints and importantly minimal TSPO expression in the
AC chondrocytes even at ages prior to any overt signs of osteoarthritic
pathology in the medial aspect (affected) of the joint. Immunolabelling
for LC3 follows the same age-related changes in expression pattern in
STR/Ort mice with marked co-localisation with TSPO within identical
chondrocytes of the AC in both strains of mice. Addition of 100nM
rapamycin to cultured STR/Ort hip explants revealed changes in the
chondrocyte mRNA expression involving a decline in levels of tran-
scripts which are normally characteristic of epiphyseal growth chon-
drocytes, with signiﬁcant decreases in Col10a1 (0.2 fold) and Enpp1 (0.2
fold) mRNA expression along with concomitant increases in pro-ana-
bolic transcripts, namely Timp1 (1.5 fold) and Col2a1 (2.9 fold) mRNA
expression in the presence of this inducer of autophagy. Despite this, no
signiﬁcant differences were observed in proteoglycan release upon
rapamycin treatment.
Conclusions: Our data show that STR/Ort mice have an inherent deﬁcit
in AC chondrocyte mitochondrial function, exhibited preferentially
within themedial tibial plateau compartment known to exhibit greatest
vulnerability to OA related AC degeneration. Initial studies indicate that
the addition of rapamycin, an inducer of autophagy, stabilises the
articular cartilage chondrocyte phenotype and as such, may offer pro-
tection against disease pathology.
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FACET JOINT OSTEOARTHRITIS IN LUMBAR SPINAL STENOSIS:
HISTOLOGICAL EVALUATION OF CELLULAR PATHOMECHANISMS
C. Netzer, K. Urech, T. H€ugle, V. Valderrabano, R. Benz, J. Geurts,
S. Sch€aren. Univ. Hosp. Basel, Basel, Switzerland
Purpose: Lumbar spinal stenosis (LSS) is a degenerative, age-related
narrowing of the lower spinal canal that causes pressure on the nerves,
leading to pain and reduced mobility. Hypertrophy of ligament ﬂava
and facet joints combined with disc protrusions are a causative for LSS.
Osteoarthritic changes to the facet joint, including joint space narrow-
ing, subchondral cysts and osteophyte formation are commonly
detected using magnetic resonance imaging (MRI) and computed
tomography (CT) scanning. However, the pathomechanisms of facet
joint osteoarthritis (OA) at a cellular and molecular level are poorly
understood and have been scarcely studied. In this study we sought to
investigate the histological features and to uncover cellular patho-
mechanisms of facet joint OA.
Methods: Fifteen patients undergoing surgical decompression due to
degenerative LSS were included in this study (9 female/6 male, medianage 66, range 49-85). Routine preoperative X-ray and MRI scanning of
the lumbar spine was performed in all subjects. Severity of facet joint
OAwas assessed in MRI images using theWeishaupt grading system for
the lumbar spine. The medial portion of facet joints was collected
during surgical decompression of the spinal canal and processed for
tissue histology. Tissue morphology was evaluated using haematoxylin
and eosin (HE), Safranin-O and van Gieson`s stains. The presence of
macrophages, blood vessels and nerve ﬁbers was investigated using
immunohistological staining for their respective markers CD68, CD34
and PGP9.5. Functional osteoclasts were visualized using tartrate-
resistant acid phosphatase (TRAP) staining. Subchondral bone area
fraction (B.Ar/T.Ar) was determined using the ImageJ-plugin BoneJ.
Results: OA was evident in MRI images as evidenced by joint space
narrowing, bone edema and cysts and hypertrophy of articular pro-
cesses (Figure 1).
The severe OA phenotype in facet joints from LSS patients was con-
ﬁrmed at a histological level by complete loss of proteoglycan staining,
CD34þ vessel penetration, and ﬁssuring of cartilage tissue. Subchondral
B.Ar/T.Ar ranged between 0.6 and 0.8. In all samples, subchondral
marrow spaces contained CD34þ blood vessels and CD68þ mono-
nuclear macrophages. CD68þmultinucleated osteoclasts were detected
in resorption pits at the bone surface in 80 percent of the patients.
Functionality of osteoclasts was conﬁrmed by positive staining of
multinucleated bone cells for TRAP in serial sections. Osteoblast activity
was demonstrated in 60 percent of the patients and predominantly
characterized by large areas of intramembranous bone formation near
the osteochondral junction (Figure 2a). Formation of an osteoclast-rich
pannus-like tissue was seen in one sample (Figure 2b).
Innervation of subchondral marrow spaces by PGP9.5-positive nerve
ﬁbers was scarce and exclusively found in the vicinity of arterioles.
Conclusions: Facet joints in LSS patients display radiological and his-
tological features of OA. Twomajor OA phenotypes can be distinguished
based upon cellular pathomechanisms in subchondral bone tissue: 1)
osteoblast-rich intramembranous bone formation and 2) osteoclast/
macrophage rich remodeling. Imaging modalities using bone-seeking
radiotracers (i.e. SPECT/CT) might enable differential diagnosis of facet
joint OA subtypes. Due to abundant osteoclast activity in facet joints,
antiresorptive treatments might represent a promising pharmaco-
logical intervention for OA-induced LSS.
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OSTEOCYTE CELL DEATH IN SUBCHONDRAL BONE FOLLOWING JOINT
INJURY CORRELATES WITH THE SEVERITY OF AGGRECAN LOSS IN
OVERLYING CARTILAGE
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